pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 1,486 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    PL-18
    Bacterial Vaginosis Jiangsu ProteLight Pharmaceutical And Biotechnology Co Ltd
  • Phase 2
    PL-8177
    Ulcerative Colitis$PTNT PALATIN TECHNOLOGIES INC
  • Phase 2
    PM-359
    Chronic Granulomatous Disease$PRME Prime Medicine, Inc.
  • Phase 2
← prev
page 22 of 50
next →
131
Pain89
Neurology1
PMD-026
Human Epidermal Growth Factor Receptor 2 Negative Breast…
Phoenix Molecular Designs
  • Phase 2
    PORT-77
    Erythropoietic Protoporphyria GondolaBio LLC
  • Phase 2
    PR-001
    Parkinson's Disease Prevail Therapeutics Inc
  • Phase 2
    PR-15
    Stroke advanceCor GmbH
  • Phase 2
    PRGN-2009
    Anal Cancer$PGEN PRECIGEN, INC.
  • Phase 2
    PRL3-ZUMAB
    Solid Tumor IISG Pte Ltd
  • Phase 2
    PRX-115
    Gouty Arthritis (Gout)$PLX Protalix BioTherapeutics, Inc.
  • Phase 2
    PS-002
    IgA Nephropathy (Berger's Disease) Purespring Therapeutics Ltd
  • Phase 2
    PSV-359
    Solid Tumor$CATX Perspective Therapeutics, Inc.
  • Phase 2
    PT-00114
    Generalized Anxiety Disorder (GAD) Protagenic Therapeutics Inc
  • Phase 2
    PTT-936
    Solid Tumor Pyrotech (Beijing) Biotechnology Co Ltd
  • Phase 2
    PTX-100
    Cutaneous T-Cell Lymphoma Prescient Therapeutics Ltd
  • Phase 2
    PTX-9908
    Hepatocellular Carcinoma Pertinax Therapeutics Inc
  • Phase 2
    PVX-108
    Peanut Allergy Aravax Pty Ltd
  • Phase 2
    PVX-7
    Human Papillomavirus (HPV) Associated Cancer PapiVax Biotech Inc
  • Phase 2
    PXL-065
    Metabolic Dysfunction-Associated Steatohepatitis (MASH or… Poxel SA
  • Phase 2
    Panaecin
    Panaecintm (gallium citrate)
    Chronic Lung Infection Aridis Pharmaceuticals Inc
  • Phase 2
    Parathyroid Hormone Inverse Agonist (PTH-IA)
    Mutational Disorders National Center for Advancing Transitional Sciences
  • Phase 2
    Peanut SLIT-tablet
    Peanut Allergy ALK-Abello AS
  • Phase 2
    Pneumostem
    Pneumostem
    Bronchopulmonary Dysplasia MediPost Co Ltd
  • Phase 2
    PolyPEPI-1018
    Metastatic Colorectal Cancer Treos Bio Ltd
  • Phase 2
    ProLectin-M
    Coronavirus Disease 2019 (COVID-19)$BIXT BIOXYTRAN, INC
  • Phase 2
    QBS-10072S
    Glioblastoma Multiforme (GBM) Quadriga BioSciences Inc
  • Phase 2
    QT-019B
    Systemic Lupus Erythematosus Hangzhou Qihan Biotechnology Co Ltd
  • Phase 2
    QTP-101
    Tuberculosis Quratis Inc
  • Phase 2
    R-289
    Myelodysplastic Syndrome (Preleukemia)$RIGL RIGEL PHARMACEUTICALS INC
  • Phase 2
    R-327
    Urinary Tract Infections Recce Pharmaceuticals Ltd